Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0545 USD | 0.00% | -9.17% | +47.30% |
Apr. 11 | North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge | DJ |
Apr. 04 | North American Morning Briefing : Focus Turns to -2- | DJ |
Business Summary
Number of employees: 18
Managers
Managers | Title | Age | Since |
---|---|---|---|
Craig Jalbert
CEO | Chief Executive Officer | 63 | - |
Martin Dekker
CTO | Chief Tech/Sci/R&D Officer | 51 | 15-01-28 |
Edwin L. Parsley
CTO | Chief Tech/Sci/R&D Officer | 63 | - |
Bobae Kim
LAW | General Counsel | 42 | 22-08-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Naseem Amin
CHM | Chairman | 62 | 15-06-28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 12,232,648 | 10,394,477 ( 84.97 %) | 0 | 84.97 % |
Company contact information
Bellerophon Therapeutics, Inc.
184 Liberty Corner Road Suite 302
07059, Warren
+908 574 4770
http://www.bellerophon.comSector
1st Jan change | Capi. | |
---|---|---|
+47.30% | 667K | |
-3.24% | 102B | |
+3.29% | 96.09B | |
-1.02% | 22.05B | |
-17.99% | 20.81B | |
-6.87% | 19.06B | |
-40.70% | 16.05B | |
-26.57% | 14.01B | |
+1.98% | 13.38B | |
+22.46% | 11.01B |
- Stock Market
- Equities
- BLPH Stock
- Company Bellerophon Therapeutics, Inc.